Addressing Cardiovascular Complications of BTK Inhibitors

H&O What are the specific cardiovascular complications that are associated with Bruton tyrosine kinase (BTK) inhibitors? JM Many cancer drugs have adverse effects on the heart […]

Bleeding Complications With Bruton Tyrosine Kinase Inhibitors

H&O What types of bleeding complications can occur with Bruton tyrosine kinase (BTK) inhibitors? TD Bleeding complications are very common and can range from minor “nuisance” […]

Bruton Tyrosine Kinase Inhibitors for the Treatment of Mantle Cell Lymphoma: Review of Current Evidence and Future Directions

Abstract: Mantle cell lymphoma (MCL) is a heterogeneous and uncommon non-Hodgkin lymphoma that affects predominantly older patients and often is associated with an aggressive clinical […]